Metagenomi Therapeutics Inc (NAS:MGX)
$ 1.2 (0%) Market Cap: 45.18 Mil Enterprise Value: -55.42 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 10/100

Metagenomi Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 9, 2026 / 03:00 PM GMT
Release Date Price: $1.23 (-4.65%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MGX.OQ - Metagenomi Therapeutics Inc
Metagenomi Therapeutics Inc Annual Shareholders Meeting
Jun 09, 2026 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the 2026 Virtual Annual Meeting of Metagiomi Therapeutics. Stockholders may submit questions by following the instructions on the Annual Meeting interface.

I would like to turn the meeting over to Gian Irish. Gian, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, everyone. My name is Gian Irish.

And I am the President and Chief Executive Officer of Metagenomics Therapeutics.

The meeting is now called to order.

I've asked Justin Plate of Goodwin Proctor LLP, our outside legal
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot